In conclusion, the benefits of GLP-1RAs in MASLD are promising, and background therapy involving metabolic modulation may represent one of the future therapeutic paradigms
doi: 10.1016/j.cca.2020.05.041 237 SallenaveJ.-M.GuillotL
Let your doctor know about any other meds youre on to avoid interactions, and report any side effects ASAP
Researchers examining inflammatory disease models, gut epithelial biology, or mucosal immunity alongside tissue repair endpoints choose KLOW
Task Force of the FRAX Initiative
137 and in B cells and neutrophils, it controls cytokine expression, migration, and lifespan, collectively preserving hepatic immune homeostasis